Mario Alcantara, MD
Colon & Rectal Surgery · San Antonio, TXNPI 1609039049
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,713 of the $14,431 with a category attached, or 81.2%. It is spread thinly across 30 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 382 payments — averaging $37.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Johnson & Johnson$2K
- Intuitive Surgical$1K
- Axonics, Inc.$1K
- Sanara Medtech Inc.$1K
- Davol Inc.$827
- plus $5K from 24 others
What the payments were for
- Speaking & faculty fees$2,09615%
- Travel & lodging$6064%
- Food & beverage$11,71381%
- Gifts$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 69 | $3,307 |
| Johnson & Johnson | 80 | $1,733 |
| Intuitive Surgical | 12 | $1,412 |
| Axonics, Inc. | 40 | $1,408 |
| Sanara Medtech Inc. | 32 | $1,232 |
| Davol Inc. | 38 | $827 |
| TELA Bio, Inc. | 7 | $800 |
| AbbVie(2 entities) | 34 | $686 |
| Medtronic(2 entities) | 14 | $628 |
| Biom'up SA | 2 | $300 |
| Shire North American Group Inc | 15 | $289 |
| Biom'up France SAS | 2 | $286 |
| Baxter Healthcare | 4 | $270 |
| Olympus America Inc. | 3 | $234 |
| Covidien LP | 4 | $189 |
| Boston Scientific | 6 | $186 |
| Lexington Medical, Inc. | 1 | $144 |
| Pacira Pharmaceuticals Incorporated | 2 | $141 |
| Redhill Biopharma Inc. | 2 | $118 |
| Integra Lifesciences Corporation | 2 | $59 |
| Ferring Pharmaceuticals Inc. | 3 | $36 |
| Kerecis Limited | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Acell, Inc. | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Ambu Inc. | 2 | $15 |
| Coloplast | 1 | $14 |
| Romark Laboratories, LC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GATTEX$1,934
- Da Vinci Surgical System$991
- CellerateRx$785
- Axonics$694
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$502
- INTERSTIM$311
- HEMOBLAST$300
- HemoBlast Bellows$286
- Ovitex$266
- Aeon Endostapler & Echelon Flex Powered Stapler$144
- Sonicision$134
- TISSEEL$129
- EXPAREL$125
- INTERSTIM ICON$125
- DISPOSABLE EMR KIT$121
- Single Use Electrosurgical Knife KD-655$121
- PerClot$118
How this compares
$14,431 in reported general payments places this provider in the 75th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 42 | $2,247,863 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 205 | $12,397 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 35 | $3,582 |
| CholestyramineCholestyramine (With Sugar) | 47 | $2,611 |
| Dicyclomine Hcl | 126 | $1,869 |
| Esomeprazole Magnesium | 15 | $1,708 |
| Pantoprazole Sodium | 153 | $1,575 |
| Lactulose | 15 | $796 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $494 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $442 |
| Metronidazole | 27 | $343 |
| Metoclopramide Hcl | 81 | $335 |
| Tramadol Hcl | 83 | $327 |
| Mirtazapine | 31 | $326 |
| Famotidine | 18 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $3,307 | $2,247,86342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 200 colon & rectal surgery providers in Texas.
Other colon & rectal surgery in San Antonio
- Christopher de JesusSan Antonio$201K
- William LewisSan Antonio$85K
- Jaime MayoralSan Antonio$84K
- Michael KellerSan Antonio$50K
- Maria Martinez UgarteSan Antonio$47K
- James PrietoSan Antonio$16K
- Rolando SaenzSan Antonio$15K
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.